Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05393791
Title Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC (ANZadapt)
Acronym ANZadapt
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Leiden University Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD | AUS


No variant requirements are available.